The synergistic effect of withaferin A combined with cisplatin on cervical cancer and its mechanism
- Author:
Wei LI
1
;
Zhong-Xiu SHI
2
;
Yong HUANG
2
;
Zhi-Ying CHENG
2
;
Jia-Hui DONG
2
;
Qing-Qing LONG
2
;
Shan HE
2
;
Tao LIU
2
;
Cheng-Cheng WANG
2
Author Information
- Publication Type:Journal Article
- Keywords: cervical cancer; cisplatin; MDR1; NF-kB; ROS; synergies; withaferin A
- From: Chinese Pharmacological Bulletin 2023;39(6):1127-1135
- CountryChina
- Language:Chinese
- Abstract: Aim To study the synergistic effect of withaferin A (WA) combined with cisplatin (DDP) on cervical cancer and its mechanism. Methods MTT assay was employed to detect the synergistic effect of WA on DDP in cervical cancer cell lines. Annexin V-FITC/PI staining, TUNEL assay and immunoblotting were used to investigate the effect of WA combined with DDP on apoptosis of cervical cancer cells. Immunofluorescence and immunoblotting were used to detect NF-kB/MDR1 pathway related proteins. DCFH-DA and MitoSOX were applied to determine the intracellular reactive oxygen species (ROS) levels. A xenograft model was also used to evaluate the synergistic effect of WA on DDP. Results The combination of WA and DDP could inhibit the survival of cervical cancer cells, promote apoptosis, and inhibit the growth of tumor in mice. WA could inhibit DDP-induced NF-kB/MDR1 signaling pathway and promote ROS production. Conclusions WA plays a synergistic role in anti-cervical cancer by inhibiting DDP-induced NF-kB/MDR1 pathway activation and enhancing DDP induced ROS production.
